• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

汞离子和甲基汞对脂质体重建的谷氨酰胺/氨基酸转运蛋白(ASCT2)的失活作用:通过同源建模预测CXXC 基序的参与。

Inactivation by Hg2+ and methylmercury of the glutamine/amino acid transporter (ASCT2) reconstituted in liposomes: Prediction of the involvement of a CXXC motif by homology modelling.

机构信息

Department of Cell Biology, University of Calabria, Via P.Bucci 4c, 87036 Arcavacata di Rende, Italy.

出版信息

Biochem Pharmacol. 2010 Oct 15;80(8):1266-73. doi: 10.1016/j.bcp.2010.06.032. Epub 2010 Jul 1.

DOI:10.1016/j.bcp.2010.06.032
PMID:20599776
Abstract

The effect of HgCl(2), methylmercury and mersalyl on the glutamine/amino acid (ASCT2) transporter reconstituted in liposomes has been studied. Mercuric compounds externally added to the proteoliposomes, inhibited the glutamine/glutamine antiport catalyzed by the reconstituted transporter. Similar effects were observed by pre-treating the proteoliposomes with the mercurials and then removing unreacted compounds before the transport assay. The inhibition was reversed by DTE, cysteine and N-acetyl-cysteine but not by S-carboxymethyl-cysteine. The data demonstrated that the inhibition was due to covalent reaction of mercuric compounds with Cys residue(s) of the transporter. The IC(50) of the transporter for HgCl(2), methylmercury and mersalyl, were 1.4+/-0.10, 2.4+/-0.16 or 3.1+/-0.19 microM, respectively. Kinetic studies of the inhibition showed that the reagents behaved as non-competitive inhibitor. The presence of glutamine or Na(+) during the incubation of the mercuric compounds with the proteoliposomes did not exerted any protective effect on the inhibition. None of the compounds was transported by the reconstituted transporter. A metal binding motif CXXC has been predicted as possible site of interaction of the mercuric compounds with the transporter on the basis of the homology structural model of ASCT2 obtained using the glutamate transporter homologue from Pyrococcus horikoshii as template.

摘要

已经研究了 HgCl(2)、甲基汞和 mersalyl 对在脂质体中重组的谷氨酰胺/氨基酸 (ASCT2) 转运体的影响。外加至蛋白脂体的汞化合物抑制了由重组转运体催化的谷氨酰胺/谷氨酰胺反向转运。在用汞化合物预处理蛋白脂体并在转运测定之前除去未反应的化合物后,观察到类似的效果。抑制作用可被 DTE、半胱氨酸和 N-乙酰半胱氨酸逆转,但不能被 S-羧甲基半胱氨酸逆转。数据表明抑制是由于汞化合物与转运体的 Cys 残基发生共价反应所致。HgCl(2)、甲基汞和 mersalyl 对转运体的 IC(50)分别为 1.4+/-0.10、2.4+/-0.16 或 3.1+/-0.19 microM。抑制的动力学研究表明,这些试剂表现为非竞争性抑制剂。在将汞化合物与蛋白脂体孵育期间存在谷氨酰胺或 Na(+),对抑制没有任何保护作用。没有一种化合物被重组转运体转运。基于 Pyrococcus horikoshii 的谷氨酸转运体同源物作为模板获得的 ASCT2 的同源结构模型,预测了 CXXC 金属结合基序可能是汞化合物与转运体相互作用的位点。

相似文献

1
Inactivation by Hg2+ and methylmercury of the glutamine/amino acid transporter (ASCT2) reconstituted in liposomes: Prediction of the involvement of a CXXC motif by homology modelling.汞离子和甲基汞对脂质体重建的谷氨酰胺/氨基酸转运蛋白(ASCT2)的失活作用:通过同源建模预测CXXC 基序的参与。
Biochem Pharmacol. 2010 Oct 15;80(8):1266-73. doi: 10.1016/j.bcp.2010.06.032. Epub 2010 Jul 1.
2
Inactivation of the glutamine/amino acid transporter ASCT2 by 1,2,3-dithiazoles: proteoliposomes as a tool to gain insights in the molecular mechanism of action and of antitumor activity.1,2,3-二噻唑类化合物对谷氨酰胺/氨基酸转运蛋白 ASCT2 的抑制作用:用于深入了解作用机制和抗肿瘤活性的质体。
Toxicol Appl Pharmacol. 2012 Nov 15;265(1):93-102. doi: 10.1016/j.taap.2012.09.011. Epub 2012 Sep 23.
3
Large scale production of the active human ASCT2 (SLC1A5) transporter in Pichia pastoris--functional and kinetic asymmetry revealed in proteoliposomes.在毕赤酵母中大规模生产活性人ASCT2(SLC1A5)转运蛋白——蛋白脂质体中揭示的功能和动力学不对称性
Biochim Biophys Acta. 2013 Sep;1828(9):2238-46. doi: 10.1016/j.bbamem.2013.05.034. Epub 2013 Jun 10.
4
The glutamine/amino acid transporter (ASCT2) reconstituted in liposomes: transport mechanism, regulation by ATP and characterization of the glutamine/glutamate antiport.脂质体中重组的谷氨酰胺/氨基酸转运体(ASCT2):转运机制、ATP调节及谷氨酰胺/谷氨酸反向转运的特性
Biochim Biophys Acta. 2007 Feb;1768(2):291-8. doi: 10.1016/j.bbamem.2006.09.002. Epub 2006 Sep 16.
5
Reconstitution into liposomes of the glutamine/amino acid transporter from renal cell plasma membrane: functional characterization, kinetics and activation by nucleotides.肾细胞质膜谷氨酰胺/氨基酸转运体在脂质体中的重组:功能特性、动力学及核苷酸激活作用
Biochim Biophys Acta. 2004 Dec 15;1667(2):122-31. doi: 10.1016/j.bbamem.2004.09.007.
6
The glutamine/amino acid transporter (ASCT2) reconstituted in liposomes: electrical nature of the glutamine/glutamate antiport.脂质体中重组的谷氨酰胺/氨基酸转运体(ASCT2):谷氨酰胺/谷氨酸反向转运的电特性
Ital J Biochem. 2007 Dec;56(4):275-8.
7
Inhibition of the OCTN2 carnitine transporter by HgCl2 and methylmercury in the proteoliposome experimental model: insights in the mechanism of toxicity.HgCl2 和甲基汞对蛋白脂质体实验模型中 OCTN2 肉碱转运体的抑制作用:对毒性机制的深入了解。
Toxicol Mech Methods. 2013 Feb;23(2):68-76. doi: 10.3109/15376516.2012.719166. Epub 2012 Oct 18.
8
The B°AT1 amino acid transporter from rat kidney reconstituted in liposomes: kinetics and inactivation by methylmercury.大鼠肾脏中重构成脂质体的B°AT1氨基酸转运体:动力学及甲基汞导致的失活
Biochim Biophys Acta. 2011 Oct;1808(10):2551-8. doi: 10.1016/j.bbamem.2011.05.011. Epub 2011 May 20.
9
Functional and molecular effects of mercury compounds on the human OCTN1 cation transporter: C50 and C136 are the targets for potent inhibition.汞化合物对人有机阳离子转运体1(OCTN1)的功能和分子效应:C50和C136是强效抑制的靶点。
Toxicol Sci. 2015 Mar;144(1):105-13. doi: 10.1093/toxsci/kfu259. Epub 2014 Dec 8.
10
Cysteine is not a substrate but a specific modulator of human ASCT2 (SLC1A5) transporter.半胱氨酸不是人ASCT2(SLC1A5)转运蛋白的底物,而是一种特异性调节剂。
FEBS Lett. 2015 Nov 30;589(23):3617-23. doi: 10.1016/j.febslet.2015.10.011. Epub 2015 Oct 19.

引用本文的文献

1
Rational design of ASCT2 inhibitors using an integrated experimental-computational approach.采用集成实验计算方法合理设计 ASCT2 抑制剂。
Proc Natl Acad Sci U S A. 2021 Sep 14;118(37). doi: 10.1073/pnas.2104093118.
2
Sulfhydryl groups as targets of mercury toxicity.巯基作为汞毒性的靶点。
Coord Chem Rev. 2020 Aug 15;417. doi: 10.1016/j.ccr.2020.213343. Epub 2020 May 7.
3
Glutamine transporters as pharmacological targets: From function to drug design.谷氨酰胺转运体作为药理学靶点:从功能到药物设计
Asian J Pharm Sci. 2020 Mar;15(2):207-219. doi: 10.1016/j.ajps.2020.02.005. Epub 2020 Mar 5.
4
Advances and Challenges in Rational Drug Design for SLCs.SLC 类药物合理设计的进展与挑战。
Trends Pharmacol Sci. 2019 Oct;40(10):790-800. doi: 10.1016/j.tips.2019.08.006. Epub 2019 Sep 10.
5
The Human SLC1A5 (ASCT2) Amino Acid Transporter: From Function to Structure and Role in Cell Biology.人类SLC1A5(ASCT2)氨基酸转运蛋白:从功能到结构及在细胞生物学中的作用
Front Cell Dev Biol. 2018 Sep 4;6:96. doi: 10.3389/fcell.2018.00096. eCollection 2018.
6
Reconstitution and functional studies of hamster P-glycoprotein in giant liposomes.巨脂质体中仓鼠 P-糖蛋白的重建和功能研究。
PLoS One. 2018 Jun 18;13(6):e0199279. doi: 10.1371/journal.pone.0199279. eCollection 2018.
7
Biomarkers of mercury toxicity: Past, present, and future trends.汞毒性的生物标志物:过去、现在及未来趋势
J Toxicol Environ Health B Crit Rev. 2017;20(3):119-154. doi: 10.1080/10937404.2017.1289834. Epub 2017 Apr 5.
8
Effects on and transfer across the blood-brain barrier in vitro-Comparison of organic and inorganic mercury species.体外对血脑屏障的影响及跨血脑屏障转运——有机汞和无机汞物种的比较
BMC Pharmacol Toxicol. 2016 Dec 15;17(1):63. doi: 10.1186/s40360-016-0106-5.
9
Alkyl Mercury-Induced Toxicity: Multiple Mechanisms of Action.烷基汞诱导的毒性:多种作用机制
Rev Environ Contam Toxicol. 2017;240:105-149. doi: 10.1007/398_2016_1.
10
Membrane transporters for the special amino acid glutamine: structure/function relationships and relevance to human health.特殊氨基酸谷氨酰胺的膜转运体:结构/功能关系及其与人类健康的相关性。
Front Chem. 2014 Aug 11;2:61. doi: 10.3389/fchem.2014.00061. eCollection 2014.